⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DCOY News
Decoy Therapeutics Inc. Common Stock
Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats
prnewswire.com
DCOY
Form 8-K
sec.gov
DCOY
Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors
prnewswire.com
DCOY
4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones
globenewswire.com
UPC
NTHI
DCOY
VRDN
Form 8-K
sec.gov
DCOY
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
prnewswire.com
DCOY
Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London
prnewswire.com
DCOY
Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors
prnewswire.com
DCOY
Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic
prnewswire.com
DCOY
Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board
prnewswire.com
DCOY